Targeting heat shock proteins in metastatic castration-resistant prostate cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting heat shock proteins in metastatic castration-resistant prostate cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 12, Issue 1, Pages 26-36
Publisher
Springer Nature
Online
2014-12-16
DOI
10.1038/nrurol.2014.320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer
- (2014) François Lamoureux et al. EUROPEAN UROLOGY
- Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
- (2013) M. Shiota et al. CANCER RESEARCH
- Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability
- (2013) H. Matsumoto et al. CANCER RESEARCH
- The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer
- (2013) Joseph Ischia et al. CURRENT OPINION IN UROLOGY
- Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
- (2013) Laia Querol Cano et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The role of heat shock proteins in bladder cancer
- (2013) Joseph Ischia et al. Nature Reviews Urology
- Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update
- (2012) Daniel R. Ciocca et al. ARCHIVES OF TOXICOLOGY
- Clusterin Mediates TGF- -Induced Epithelial-Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells
- (2012) M. Shiota et al. CANCER RESEARCH
- Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors
- (2012) M. M. Centenera et al. CLINICAL CANCER RESEARCH
- Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer
- (2012) Robert Zielinski et al. Future Oncology
- Small heat shock proteins in cancer therapy and prognosis
- (2012) Amina Zoubeidi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- HSP90 and HSP70 Proteins Are Essential for Stabilization and Activation of WASF3 Metastasis-promoting Protein
- (2012) Yong Teng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer
- (2012) Michael W. Hance et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reply to W.R. Robinson
- (2012) Dennis S. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Cotargeting Stress-Activated Hsp27 and Autophagy as a Combinatorial Strategy to Amplify Endoplasmic Reticular Stress in Prostate Cancer
- (2012) M. Kumano et al. MOLECULAR CANCER THERAPEUTICS
- Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer
- (2012) Virginie Baylot et al. MOLECULAR THERAPY
- GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer
- (2012) N Li et al. ONCOGENE
- Post-translational modifications of Hsp90 and their contributions to chaperone regulation
- (2011) Mehdi Mollapour et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells
- (2011) Jeffery D Eskew et al. BMC CANCER
- Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate Cancer
- (2011) F. Lamoureux et al. CANCER RESEARCH
- Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch
- (2011) N Hayashi et al. CELL DEATH AND DIFFERENTIATION
- A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis
- (2011) F. Lamoureux et al. CLINICAL CANCER RESEARCH
- A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas
- (2011) A. Rajan et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c
- (2011) F. Saad et al. CLINICAL CANCER RESEARCH
- A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
- (2011) Simon Pacey et al. CLINICAL CANCER RESEARCH
- mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer
- (2011) Sujit K. Bhutia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically
- (2011) Charles J. Ryan et al. JOURNAL OF CLINICAL ONCOLOGY
- Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer
- (2011) M. Shiota et al. MOLECULAR CANCER RESEARCH
- Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance
- (2011) Katherine J. O'Malley et al. PROSTATE
- Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer
- (2011) William K. Oh et al. UROLOGY
- Targeting heat shock proteins in cancer
- (2010) Gaëtan Jego et al. CANCER LETTERS
- Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD
- (2010) A. Zoubeidi et al. CANCER RESEARCH
- Preclinical Characterization of Mitochondria-Targeted Small Molecule Hsp90 Inhibitors, Gamitrinibs, in Advanced Prostate Cancer
- (2010) B. H. Kang et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Kim N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Heat Shock Protein 27 Is Required for Sex Steroid Receptor Trafficking to and Functioning at the Plasma Membrane
- (2010) M. Razandi et al. MOLECULAR AND CELLULAR BIOLOGY
- Induction of Clusterin by AKT--Role in Cytoprotection against Docetaxel in Prostate Tumor Cells
- (2010) B. Zhong et al. MOLECULAR CANCER THERAPEUTICS
- HSP90 at the hub of protein homeostasis: emerging mechanistic insights
- (2010) Mikko Taipale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Heat shock factors: integrators of cell stress, development and lifespan
- (2010) Malin Åkerfelt et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Detecting soluble Clusterin in in-vitro and in-vivo models of prostate cancer
- (2010) F. Girard et al. NEOPLASMA
- Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
- (2010) C Andrieu et al. ONCOGENE
- Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
- (2009) C S Foster et al. BRITISH JOURNAL OF CANCER
- Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway
- (2009) Teh-Ying Chou et al. CELLULAR SIGNALLING
- Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies
- (2009) A E G Lenferink et al. ONCOGENE
- Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis
- (2009) H Song et al. ONCOGENE
- Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells
- (2009) Shawna B. Matthews et al. PROSTATE
- Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy
- (2008) Richard D. Sowery et al. BJU INTERNATIONAL
- Down-regulation of Mammalian Sterile 20-Like Kinase 1 by Heat Shock Protein 70 Mediates Cisplatin Resistance in Prostate Cancer Cells
- (2008) A. Ren et al. CANCER RESEARCH
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase Dependent Cancers
- (2008) S. Chandarlapaty et al. CLINICAL CANCER RESEARCH
- A Phase I Study of OGX-011, a 2'-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer
- (2008) K. N. Chi et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
- (2008) E. I. Heath et al. CLINICAL CANCER RESEARCH
- Heat shock proteins: Stress proteins with Janus-like properties in cancer
- (2008) Stuart K. Calderwood et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Protective Role of Hsp27 Protein Against Gamma Radiation–Induced Apoptosis and Radiosensitization Effects of Hsp27 Gene Silencing in Different Human Tumor Cells
- (2008) Marie-Thérèse Aloy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clusterin Activates Survival through the Phosphatidylinositol 3-Kinase/Akt Pathway
- (2008) Hayet Ammar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clusterin, a novel modulator of TGF-β signaling, is involved in Smad2/3 stability
- (2007) Kwan-Bok Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started